Insider Trading & Ownership - Cavu Management LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cavu Management LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-14
Sale(A)
2024-08-20
8:45 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
24,999$8$199,992131,248
(Indirect)
View
2024-08-14
Purchase
2024-08-14
8:44 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
500,000$8$4,000,000216,083
(Indirect)
View
2024-08-14
Sale
2024-08-14
8:44 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
24,999$9$224,991216,083
(Indirect)
View
2024-05-23
Sale
2024-05-28
4:31 pm
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
30,000$6.3033$189,100747,049
(Indirect)
View
2024-02-27
Sale
2024-02-29
9:54 pm
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
144,000$4.6965$676,294753,428
(Indirect)
View
2024-01-17
Sale
2024-01-19
4:30 pm
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
58,889$4.2$247,334784,013
(Indirect)
View
2023-11-29
Sale
2023-12-01
06:00 am
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
145,348$3.44$499,9971,170,117
(Indirect)
View
2023-06-21
Purchase
2023-06-23
9:38 pm
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
2,297,490$1.3058$3,000,000527,195
(Indirect)
View
2022-12-12
Purchase
2022-12-13
07:01 am
IN8BIO INC.INABKreis Leslie W.
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
75,001$2.4788$185,9124,270,424
(Indirect)
View
2022-11-28
Purchase
2022-11-29
07:00 am
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Director
10% Owner
16,064$2.6497$42,5653,151,266
(Indirect)
View
2022-11-16
Purchase
2022-11-17
07:00 am
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Director
71,000$1.4$99,4003,149,395
(Indirect)
View
2022-11-15
Purchase
2022-11-16
06:59 am
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Director
1,500,000$1.2$1,800,0003,141,126
(Indirect)
View
2022-11-08
Sale
2022-11-09
9:39 pm
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
350,000$4.4$1,540,000164,137
(Indirect)
View
2022-09-28
Purchase
2022-09-29
06:08 am
IN8BIO INC.INABKreis Leslie W.
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
25,000$2.0214$50,5354,261,689
(Indirect)
View
2022-09-02
Sale
2022-09-07
4:54 pm
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
6,445$5.2$33,5141,889,456
(Indirect)
View
2022-08-26
Purchase
2022-08-30
1:16 pm
IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
51,214$2.0178$103,3404,258,776
(Indirect)
View
2022-08-26
Purchase
2022-08-30
08:10 am
IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
51,214$2.0178$103,3404,258,776
(Indirect)
View
2022-08-17
Purchase
2022-08-18
8:00 pm
IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
50,000$1.93$96,5004,252,810
(Indirect)
View
2022-08-17
Purchase
2022-08-18
7:16 pm
IN8BIO INC.INABFletcher Aaron G.L.
BIOS Equity Partners III LP
Cavu Management LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner
50,000$1.93$96,5004,252,810
(Indirect)
View
2022-08-16
Purchase
2022-08-17
10:27 am
IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund III QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner
1,773,684$1.9$3,370,0004,348,150
(Indirect)
View
2022-08-16
Purchase
2022-08-17
10:25 am
IN8BIO INC.INABFletcher Aaron G.L.
BIOS Equity Partners III LP
Cavu Management LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner
1,773,684$1.9$3,370,0004,348,150
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-04
Disposition
2024-10-11
6:13 pm
2023-12-13
2025-06-13
IN8BIO INC.INABKreis Leslie W.
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
BP Directors LP
Bios Equity Partners LP
Cavu Management LP
Cavu Advisors LLC
10% Owner
574,241$011,862,579
(Indirect)
View
2024-10-04
Option Award
2024-10-11
6:13 pm
2023-12-13
2025-10-04
IN8BIO INC.INABKreis Leslie W.
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
BP Directors LP
Bios Equity Partners LP
Cavu Management LP
Cavu Advisors LLC
10% Owner
574,241$011,862,579
(Indirect)
View
2024-08-14
Exercise
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
37,951$0216,083
(Indirect)
View
2024-08-14
Exercise
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
37,951$5.27216,083
(Indirect)
View
2024-08-14
Conversion
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
9,380,699$0216,083
(Indirect)
View
2024-08-12
Option Award
2024-08-14
8:44 pm
N/A
2034-08-12
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
15,000$0216,083
(Indirect)
View

Ownership
2024-08-12
6:29 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
0$08,835,435
(Indirect)
View
2024-06-07
Option Award
2024-06-11
9:33 pm
N/A
2034-06-07
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BP Directors LP
Director
10% Owner
8,500$06,023,000
(Indirect)
View
2024-01-17
Exercise
2024-01-19
4:30 pm
2019-03-07
2024-03-07
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
79,021$0784,013
(Indirect)
View
2024-01-17
Exercise
2024-01-19
4:30 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
79,021$3.13784,013
(Indirect)
View
2023-11-08
Option Award
2023-11-13
09:48 am
N/A
N/A
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BP Directors LP
Director
10% Owner
500,095$1.056,012,000
(Indirect)
View
2023-06-21
Conversion
2023-06-23
9:38 pm
N/A
N/A
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
6,807,032$0527,195
(Indirect)
View

Ownership
2023-06-15
5:55 pm
N/A
N/A
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
0$04,535,218
(Indirect)
View
2023-06-09
Option Award
2023-06-13
8:02 pm
N/A
2033-06-09
COGNITION THERAPEUTICS INCCGTXKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Equity Partners III LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
Director
10% Owner
6,000$05,511,905
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:54 pm
2018-12-17
2028-12-16
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
32,538$01,889,456
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:54 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
10% Owner
32,538$1.031,889,456
(Indirect)
View
2022-06-10
Other(A)
2022-06-30
12:06 pm
N/A
2023-06-10
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Cavu Advisors LLC
Kreis Leslie W.
Director
10% Owner
13,273$023,253
(Direct)
View
2022-06-10
Other
2022-06-14
7:57 pm
N/A
2023-06-10
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Cavu Advisors LLC
Director
10% Owner
13,273$023,253
(Direct)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
2017-03-17
2022-03-17
Lantern Pharma Inc.LTRNKreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779$01,292,887
(Indirect)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779$3.131,292,887
(Indirect)
View
2022-01-31
Other
2022-02-01
7:51 pm
N/A
2031-02-23
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Kreis Leslie W.
Director
10% Owner
2,290$03,864
(Direct)
View
2021-10-13
Conversion(A)
2022-02-01
7:03 pm
N/A
N/A
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Kreis Leslie W.
Director
10% Owner
1,424,014$01,424,014
(Indirect)
View

Ownership(A)
2022-02-01
6:22 pm
N/A
2031-02-23
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Kreis Leslie W.
Director
10% Owner
0$01,431,742
(Direct)
View
2021-11-04
Option Award
2021-11-08
5:23 pm
N/A
2031-11-04
Lantern Pharma Inc.LTRNKreis Leslie W.
BP Directors LP
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
Director
10% Owner
3,200$01,764,346
(Indirect)
View
2021-08-13
Other
2021-08-17
7:55 pm
N/A
2029-03-11
IN8BIO INC.INABKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
10% Owner
23,275$023,275
(Indirect)
View
2021-08-03
Conversion
2021-08-03
4:57 pm
N/A
N/A
IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner
12,649,578$0359,374
(Indirect)
View

Ownership
2021-07-29
9:36 pm
N/A
N/A
IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner
0$06,625,102
(Indirect)
View
2020-06-15
Conversion
2020-06-16
6:21 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
2,293,804$098,657
(Indirect)
View
2020-06-15
Option Award
2020-06-16
6:21 pm
N/A
2030-06-14
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
9,135$098,657
(Direct)
View

Ownership
2020-06-10
7:17 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Cavu Management LP
Cavu Advisors LLC
BP Directors LP
Director
10% Owner
0$01,968,478
(Indirect)
View
(A) Indicate amendment filing.